NCT03646474View on ClinicalTrials.gov

Single Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery and HIPEC

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Cytoreductive Surgery
Interventions
DRUG

tranexamic Acid infusion

The tranexamic Acid group will receive an intravenous bolus of (10 mg/kg) in 100 ml of normal saline over 20 minutes after induction of anesthesia and before surgical incision.

DRUG

saline infusion

In the placebogroup, patients will receive a placebo of 100 mL 0.9% normal saline.

Trial Locations (1)

Unknown

National Cancer Institute, Cairo University, Cairo

All Listed Sponsors
lead

Assiut University

OTHER

NCT03646474 - Single Dose Tranexamic Acid in Reducing Blood Loss During Cytoreductive Surgery and HIPEC | Biotech Hunter | Biotech Hunter